Ipca Laboratories Ltd.

Financial

	Ipca Laboratories	Glenmark Pharma	Ajanta Pharma
Operational Metrics
API Sector
US DMF Filings	55.0 .	n/a	n/a
Pharmaceutical Sector
Number of ANDA's Filed in USA	43.0 .	13.0 .	74.0 .
Number of ANDA's Approved By USFDA	21.0 .	25.0 .	53.0 .
Domestic Sales Growth - YoY	7.6 %	10.1 %	15.6 %
R&D as a % of Total Sales	2.64 %	6.6 %	5.0 %
Financials
5 yr Average ROE	14.77 %	4.18 %	20.38 %
5yr average Equity Multiplier	1.47	1.88	1.34
5yr Average Asset Turnover Ratio	0.79	0.79	0.79
5yr Avg Net Profit Margin	12.85 %	2.73 %	19.43 %
Price to Book	5.57	4.72	9.11
P/E	51.14	0.0	37.33
5yr Avg Cash Conversion Cycle	62.7 Days	-121.67 Days	-93.41 Days
Inventory Days	101.09 Days	40.44 Days	61.2 Days
Days Receivable	63.37 Days	36.38 Days	52.69 Days
Days Payable	112.44 Days	201.37 Days	198.04 Days
5yr Average Interest Coverage Ratio	55.69	3.48	108.17
5yr Avg ROCE	18.16 %	16.29 %	25.98 %
5yr Avg Operating Profit Margin	19.9 %	15.62 %	27.51 %
5 yr average Debt to Equity	0.16	0.49	0.0
5yr CAGR Net Profit	-2.03 %	n/a	11.78 %
5yr Average Return on Assets	10.46 %	1.86 %	15.32 %
Shareholdings
Promoter Holding	44.72 %	46.65 %	66.26 %
Share Pledged by Promoters	0.0	0.0	12.61 %
Change in Promoter Holding (3 Yrs)	-1.57 %	0.0	-4.22 %
Change in Mutual Fund Holding (3 Yrs)	1.43 %	6.68 %	4.63 %

Business

	Ipca Laboratories	Glenmark Pharma	Ajanta Pharma
Product Wise Break-Up	Product Wise Break-Up Branded Generics 49.34 Formulations 31.07 Active Pharmaceutical Ingredient (API) 19.59 Glenmark Pharma (Branded generics) 0 Glenmark generics 0 Pharmaceutical products 0	Product Wise Break-Up Branded Generics 60.46 Branded Generics 0 Formulations 39.54 Pharmaceutical products 0 Active Pharmaceutical Ingredient (API) 0 Formulations 0	Product Wise Break-Up Glenmark Pharma (Branded generics) 0 Branded Generics 0 Glenmark generics 0 Pharmaceutical 100.0 Active Pharmaceutical Ingredient (API) 0 Formulations 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Pain 52.0 Cardiac Science 17.0 Dermatology 6.0 Anti-bacterial 6.0 Urology 4.0 Cough and colds 4.0 Central Nervous System (CNS) 3.0 Anti Malarials 3.0 Gastro Intestinal 2.0 Neutraceuticals 1.0 0 Others 2.0	-	Therapeutic Area Wise Break-Up - Domestic Anti-bacterial 0 Anti Malarials 0 Cough and colds 0 0 Pain 9.0 Central Nervous System (CNS) 0 Cardiac Science 0 Gastro Intestinal 0 Urology 0 Neutraceuticals 0 Dermatology 23.0 Others 68.0
Location Wise Break-Up	Location Wise Break-Up India 46.34 USA 17.83 Europe 15.39 Africa 6.96 Asia Pacific 6.08 Australia 4.05 CIS 3.35 Rest of the World 0 Latin America 0 North America 0 Asia 0	Location Wise Break-Up Rest of the World 22.11 North America 23.06 USA 0 CIS 0 Europe 21.54 Asia Pacific 0 India 31.4 Australia 0 Latin America 0 Africa 0 Asia 0 Others 1.89	Location Wise Break-Up Rest of the World 0 North America 0 USA 19.55 CIS 0 Europe 0 Asia Pacific 0 India 32.52 Australia 0 Latin America 0 Africa 21.57 Asia Pacific 24.94 Others 1.42
Therapeutic Area Break-Up	Therapeutic Area Break-Up Cardiovascular & Anti Diabetics 25.0 Anti Malarials 24.0 NSAID 21.0 Neuro 7.0 GI 6.0 Cough 2.0 Nutraceuticals 0 Urology 0 Dermatology 0 Others 15.0	-	-

Ipca Laboratories Ltd.

SIGN UP FOR FREE